LEO Pharma develops, manufactures and markets pharmaceutical drugs, primarily to treat dermatological conditions. Over the past two years, the company has implemented an ambitious growth strategy with a more global and patient-centric focus. It has set up 11 international affiliates in key international markets, including the US which now accounts for 20% of total Group net sales.
+ 44 (0)20 7234 3535